Roche, Ortho-Clinical Diagnostics Debut Competing Hepatitis B Tests
This article was originally published in The Gray Sheet
Executive Summary
Roche Diagnostics will tout the speed of its Elecsys qualitative hepatitis B surface antigen (HBsAg) immunoassay as a key competitive advantage over Ortho-Clinical Diagnostics' Vitros qualitative HBsAg test in marketing the test to clinical labs, the firm says.